Explore a selection of our essential drug information below, or:
Identification
- Summary
Acacia is an extract from Acacia used in allergy testing.
- Generic Name
- Acacia
- DrugBank Accession Number
- DB10451
- Background
Acacia allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Acacia
- Acacia ampliceps gum
- Acacia arabica
- Acacia circummarginata resin
- Acacia cufodontii resin
- Acacia dealbata gum
- Acacia fragilis gum
- Acacia gum
- Acacia leptopetala gum
- Acacia ligulata gum
- Acacia meisneri gum
- Acacia mucilage
- Acacia oxyosprion resin
- Acacia powder
- Acacia pruinocarpa gum
- Acacia rupestris resin
- Acacia salicina gum
- Acacia senegal
- Acacia senegal gum
- Acacia senegal gum extract
- Acacia senegal resin
- Acacia seyal
- Acacia spinosa resin
- Acacia verek resin
- Acacia victoriae gum
- Acacia volkii resin
- Acacia, spray-dried
- Acaciae gummi
- Arabic gum
- Arabic gum allergenic extract
- Gum acacia
- Gum arabic
- Gum arabic (acacia senegal)
- Gum arabic (acacia seyal)
- Gum senegal
- Gummi arabicum
- Kher resin
- Kordofan gum
- Mimosa senegal resin
- Plants and plant parts, gum, acacia or arabic acacia senegal
- Rfaudraksha resin
- Senegal gum
- Senegalia senegal resin
- Thorny acacia resin
- External IDs
- Fema no. 2001
- INS NO.414
- INS-414
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Acacia Injection, solution 0.05 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US 
Acacia Injection, solution 1000 [PNU]/1mL Intradermal ALK-Abello, Inc. 1965-01-01 2023-05-22 US Acacia Injection, solution 0.10 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-18 US Acacia Injection, solution 0.05 g/1mL Percutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US Acacia Pollen Injection, solution 1 g/20mL Percutaneous; Subcutaneous Allergy Laboratories, Inc. 1967-12-07 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 5C5403N26O
- CAS number
- 9000-01-5
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.10 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Solution Intradermal; Percutaneous; Subcutaneous 100 mg/1ml Solution Intradermal; Percutaneous; Subcutaneous 50 mg/1ml Injection, solution Intradermal; Subcutaneous 0.005 g/1mL Injection, solution Intradermal; Subcutaneous 0.01 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.005 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.01 g/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at February 21, 2021 18:52